Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Martek Biosciences

This article was originally published in The Tan Sheet

Executive Summary

Martek Biosciences: Signs letter of intent to acquire a Winchester, Ky. fermentation facility for $10 mil. in cash, stock, and promissory notes from Golden Technologies Company. Martek plans to produce DHA (docosahexaenoic acid) and ARA (arachidonic acid) microbial triglyceride oils, the components of its Formulaid infant formula ingredient, at the plant. In December 1994, Martek received a patent for the DHA/ARA blend as well as blends used for supplementing infant formula such as ARA microbial oils with certain fish oils, and DHA microbial oils with vegetable oil sources of gamma linoleic acid. To date, American Home Products, Mead Johnson and Nutricia have signed license agreements with Martek to include Formulaid in their infant formulas, and Nutricia has launched a pre-term infant formula containing Formulaid in Belgium...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel